@article{article_1073681, title={Low-Dose Methotrexate Toxicity in a Hemodialysis Patient: A Case Report}, journal={Turkish Journal of Internal Medicine}, volume={4}, pages={175–177}, year={2022}, DOI={10.46310/tjim.1073681}, author={Sezen, Mehmet and Yüksel, Tuğçe and Göktuğ, Mehmet Refik and Yıldız, Abdülmecit}, keywords={Methotrexate Toxicity, Hemodialysis, psoriasis}, abstract={Methotrexate (MTX) is an effective drug used to treat various diseases, especially rheumatological diseases. However, myelosuppression is a severe side effect, the frequency of which increases in patients with renal insufficiency. Here, we presented a chronic hemodialysis patient who developed pancytopenia and mucositis after using low-dose MTX to treat psoriasis.}, publisher={Nizameddin KOCA}